A recent study by North Carolina State University exposes a critical shortfall in opioid treatment availability within the ...

Intellia Therapeutics received the FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for nexiguran ziclumeran ...

Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has received a Notice of Publication of ...

Photo: Paramedics attend to a man who is overdosing, in the Drexel neighborhood of Dayton, Ohio, on Aug. 3, 2017. The Epoch ...

Dr. Jay Bhattacharya Bhattacharya is a physician and professor at Stanford University School of Medicine, and is a critic of ...

Lexicon Pharmaceuticals has completed the enrolment of subjects for the multicentre, Phase IIb PROGRESS trial of the new ...

US President-elect Donald Trump has picked Dr Jay Bhattacharya, a health economist and critic of pandemic lockdowns and ...

A collection of common and new medications is showing good results against the constellation of symptoms that individualize ...

Lexicon completes patient enrollment in phase 2B PROGRESS study of LX9211 in diabetic peripheral neuropathic pain: The Woodlands, Texas Thursday, November 28, 2024, 12:00 Hrs [IST ...

A 22-year-old found dead in the front seat of his car had taken protonitazene pills, a drug “more powerful than fentanyl,” ...